Inbound open innovation in biopharmaceutical firms: unpacking the role of absorptive capacity

T Russo-Spena, N Di Paola - … Analysis & Strategic Management, 2019 - Taylor & Francis
… In the high-tech businesses, as the biopharmaceutical one, the explorative relationships (ie …
of firms’ open innovation strategies, at the organisational and inter-organisational levels, was …

Effects of open innovation on organizational capabilities and design: the case of biopharmaceuticals

D Tamoschus - 2022 - opus4.kobv.de
explorativeorganizational patterns of making use of external knowledge sources in the
biopharmaceutical ecosystem. This thesis is an attempt to study the emerging open innovation

Introducing the open innovation model in Polish biopharmaceutical companies: major drivers and barriers

J Leśniowska - ceeol.com
… lagged in implementing open innovation lie in their organizational mindset and administrative
… Factors affecting outbound open innovation Performance in Bio-Pharmaceutical industry-…

What drives biopharmaceutical firms' exploratory openness? A comparative process tracing approach to the analysis of R&D microfoundations

N Di Paola, TR Spena - Journal of Business Research, 2019 - Elsevier
… for a multidimensional approach in the open innovation domain, the … which exploratory
openness is encouraged and enacted. … To support open search over time, organisations need to …

[HTML][HTML] Factors affecting outbound open innovation performance in bio-pharmaceutical industry-focus on out-licensing deals

E Kim, IG Lee, H Kim, K Shin - Sustainability, 2021 - mdpi.com
… Based on the literature, in this study, the organizational dimension of licensee’s absorptive
capacity is considered by the number of in-licensing. In addition, we considered the number …

Implementing open innovation in a closed biopharmaceutical industry

S Ghazinoory, M Nozari, H Siadati - … , Technology, Innovation and …, 2024 - Taylor & Francis
… The present study is exploratory-descriptive in terms of purpose … that is, the effective
organization of research and … bio-pharmaceutical industry companies had succeeded through …

[HTML][HTML] Open innovation in medical and pharmaceutical research: a literature landscape analysis

AWK Yeung, AG Atanasov, H Sheridan… - Frontiers in …, 2021 - frontiersin.org
organizational boundaries, using pecuniary and nonpecuniary mechanisms in line with the
organization's … cited articles, for example, an exploratory analysis on the top 20 worldwide …

Technology sourcing and the dark side of open innovation: evidence from the biopharmaceutical sector

L Purdy, H Eslami, K Eshghi, M Rod - Technovation, 2023 - Elsevier
… Benchmark report stated that 61% of surveyed organisations used an open innovation
model to drive innovation in their firms, while 35% of companies said customers are their most …

Exploring Open Innovation in the Biotechnology Industry: A Qualitative Study

H Sood - 2020 - vuir.vu.edu.au
organisations; and to explore how organisations and individuals can manage these implications.
The results of this study … this study makes is that OI is closely linked to Organisational

Productivity of the Korean Biopharmaceutical Industry: Exploring the Effect of Business Model and Open Innovation

J Yang, E Kim - Science, Technology and Society, 2024 - journals.sagepub.com
… The relation among organizational culture, knowledge management, and … Efficiency and
productivity of publicly-traded bio-pharmaceutical companies in Taiwan. Paper presented at the …